Standout Papers
Citation Impact
Citing Papers
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
2006 StandoutNobel
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
Lipoprotein Electrophoretic Patterns, Serum Lipids, and Coronary Heart Disease
1971
Serum cholesterol, cholesterol precursors, and plant sterols in hypercholesterolemic subjects with different apoE phenotypes during dietary sitostanol ester treatment
1993
Electrophoretic separation of plasma lipoproteins in agarose gel
1968
Receptor-mediated low density lipoprotein catabolism in man.
1979
Three-pool model of the long-term turnover of plasma cholesterol in man
1973
Rabbit Serum Paraoxonase 3 (PON3) Is a High Density Lipoprotein-associated Lactonase and Protects Low Density Lipoprotein against Oxidation
2000
Serum cholesterol and cholesterol and lipoprotein metabolism in hypercholesterolaemic NIDDM patients before and during sitostanol ester-margarine treatment
1994
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
Toward the quiescent coronary plaque
1993
High Density Lipoproteins Facilitate Hepatitis C Virus Entry through the Scavenger Receptor Class B Type I
2005
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery
2002 Standout
Treatment of severe familial hypercholesterolemia in childhood with sitosterol and sitostanol
1993
Cellular Cholesterol Efflux Mediated by Cyclodextrins
1995 Standout
The mechanosensory protein MEC-6 is a subunit of the C. elegans touch-cell degenerin channel
2002 StandoutNatureNobel
Nutrition and platelet function in atherogenesis
1987
In vivo quantification of cholesterol content in human carotid arteries by quantitative Gamma-camera imaging after injection of autologous low density lipoproteins (LDL)
1992
Lack of efficacy of low-dose sitostanol therapy as an adjunct to a cholesterol-lowering diet in men with moderate hypercholesterolemia
1995
Dietary -sitostanol related to absorption, synthesis and serum level of cholesterol in different apolipoprotein E phenotypes
1994
Atherosclerosis — An Inflammatory Disease
1999 Standout
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis
1995 Standout
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
Reduction of Serum Cholesterol with Sitostanol-Ester Margarine in a Mildly Hypercholesterolemic Population
1995 Standout
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
Clinical significance of coronary arterial ectasia
1976
Normalization of Low-Density-Lipoprotein Levels in Heterozygous Familial Hypercholesterolemia with a Combined Drug Regimen
1981
Coated pits, coated vesicles, and receptor-mediated endocytosis
1979 StandoutNatureNobel
GENETICS OF HYPERLIPOPROTEINÆMIAS
1971
The Metabolic Role of Lecithin: Cholesterol Acyltransferase: Perspectives from Pathology
1973
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
2003 Standout
LDL receptors in coated vesicles isolated from bovine adrenal cortex: Binding sites unmasked by detergent treatment
1980 StandoutNobel
SERUM LIPOPROTEIN PATTERN IN MYOCARDIAL INFARCTION
1970
Studies on the composition and structure of plasma lipoproteins
1972
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
1975 Standout
Radiotracers for low density lipoprotein biodistribution studies in vivo: technetium-99m low density lipoprotein versus radioiodinated low density lipoprotein preparations.
1988
The Interaction between Human Plasma Lipoproteins and Connective Tissue Glycosaminoglycans
1972
Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid.
1983
Effect of low-dose sitostanol on serum cholesterol in patients with hypercholesterolemia
1986
Reduction in cholesterol and low density lipoprotein synthesis after portacaval shunt surgery in a patient with homozygous familial hypercholesterolemia.
1975
Functional rafts in cell membranes
1997 StandoutNature
Abnormal lipid composition of very low density lipoproteins in diagnosis of broad-beta disease (Type III hyperlipoproteinemia)
1972
Familial Type IV Hyperlipoproteinemia
1969
Hyperlipidemia in Coronary Heart Disease II. GENETIC ANALYSIS OF LIPID LEVELS IN 176 FAMILIES AND DELINEATION OF A NEW INHERITED DISORDER, COMBINED HYPERLIPIDEMIA
1973 StandoutNobel
Physicochemical and histological changes in the arterial wall of nonhuman primates during progression and regression of atherosclerosis.
1984
Genetics of the LDL receptor: Evidence that the mutations affecting binding and internalization are allelic
1977 StandoutNobel
Neonatal familial type II hyperlipoproteinemia: Cord blood cholesterol in 1800 births
1971
Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals.
1995 StandoutNobel
Structural studies on serum lipoproteins
1972
CHOLESTEROL METABOLISM IN THE MACROPHAGE
1971
Familial hypercholesterolemia: Defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme a reductase activity
1974 StandoutNobel
Magnitude of the host nutritional responses to infection
1977
Classification of Hyperlipidaemias and Hyperlipoproteinaemias ,
1972
Complexes of low-density lipoproteins and arterial proteoglycan aggregates promote cholesteryl ester accumulation in mouse macrophages
1985
Mechanisms of action of plant sterols on inhibition of cholesterol absorption
1991
Effect of strenuous exercise on platelet activation state and reactivity.
1993
Inheritance of combined hyperlipoproteinemia: Evidence for a new lipoprotein phenotype
1973
An International Classification of Hyperlipidemias and Hyperlipoproteinemias
1971
Canine Lipoproteins and Atherosclerosis
1974
Familial Hypercholesterolemia: A Genetic Defect in the Low-Density Lipoprotein Receptor
1976
Regulation of Plasma Cholesterol by Lipoprotein Receptors
1981 StandoutScienceNobel
Abnormal lipid composition of chylomicrons in broad-β disease (type III hyperlipoproteinemia)
1970
RISKS OF ISCHÆMIC HEART-DISEASE IN FAMILIAL HYPERLIPOPROTEINÆMIC STATES
1969
Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart Disease
1971 Standout
Lipid and carbohydrate abnormalities in patients with angiographically documented coronary artery disease
1969
Type III and IV familial hyperlipoproteinemia
1968
A Heritable Hyperlipemic Rabbit
1975
Acute tendinitis and arthritis. A presenting symptom of familial type II hyperlipoproteinemia
1968
Internalization-defective LDL receptors produced by genes with nonsense and frameshift mutations that truncate the cytoplasmic domain
1985 StandoutNobel
Hyperlipidemia in Coronary Heart Disease III. EVALUATION OF LIPOPROTEIN PHENOTYPES OF 156 GENETICALLY DEFINED SURVIVORS OF MYOCARDIAL INFARCTION
1973 StandoutNobel
Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens.
1981
Ischemic Heart Disease in Young Adults
1968
LIPID ABNORMALITIES IN MALE AND FEMALE SURVIVORS OF MYOCARDIAL INFARCTION AND THEIR FIRST-DEGREE RELATIVES
1972
LACK OF INHIBITION OF HEPATIC CHOLESTEROL SYNTHESIS BY DIETARY CHOLESTEROL IN CASES OF FAMILIAL HYPERCHOLESTEROLÆMIA
1969
Novel Proteinaceous Infectious Particles Cause Scrapie
1982 StandoutScienceNobel
Regulation of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Activity in Human Fibroblasts by Lipoproteins
1973 StandoutNobel
Typing of hyperlipoproteinaemias
1970
Familial Hypercholesterolemia: Identification of a Defect in the Regulation of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Activity Associated with Overproduction of Cholesterol
1973 StandoutNobel
Cachectin: More Than a Tumor Necrosis Factor
1987 StandoutNobel
Hyperlipidaemic xanthomatosis. II. Mode of inheritance in 55 families with essential hyperlipidaemia and xanthomatosis.
1968
Delayed clearance of very low density and intermediate density lipoproteins with enhanced conversion to low density lipoprotein in WHHL rabbits.
1982 StandoutNobel
Typing of hyperlipoproteinemias
1970
The LDL Pathway in Human Fibroblasts: A Receptor-Mediated Mechanism for the Regulation of Cholesterol Metabolism
1976 StandoutNobel
Homozygous familial hypercholesterolemia mutant with a defect in internalization of low density lipoprotein.
1981
Therapeutic effects of ML-236B in primary hypercholesterolemia
1980
Serum Lipids in Infection
1969
Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction
1979 Standout
The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia
1972
Role of the coated endocytic vesicle in the uptake of receptor-bound low density lipoprotein in human fibroblasts
1977 StandoutNobel
Measurements of cholesterol turnover, synthesis, and absorption in man, carried out by isotope kinetic and sterol balance methods
1969
Specific binding sites for albumin restricted to plasmalemmal vesicles of continuous capillary endothelium: receptor-mediated transcytosis.
1986
Optimizing the effect of plant sterols on cholesterol absorption in man
1982
Metabolic Studies in Familial Hypercholesterolemia
1979
Serum Lipids and Glucose Tolerance in Angiographically Proved Coronary Artery Disease
1970
THE LOW‐DENSITY LIPOPROTEIN PATHWAY IN HUMAN FIBROBLASTS: RELATION BETWEEN CELL SURFACE RECEPTOR BINDING AND ENDOCYTOSIS OF LOW‐DENSITY LIPOPROTEIN*
1976 StandoutNobel
Monensin interrupts the recycling of low density lipoprotein receptors in human fibroblasts
1981 StandoutNobel
Release of low density lipoprotein from its cell surface receptor by sulfated glycosaminoglycans
1976 StandoutNobel
A mutation that impairs the ability of lipoprotein receptors to localise in coated pits on the cell surface of human fibroblasts
1977 StandoutNatureNobel
Coronary Plaque Disruption
1995 Standout
The interaction of cholesterol absorption and cholesterol synthesis in man
1969
Thermal Transitions in Human Plasma Low Density Lipoproteins
1975 Science
Detection of individual susceptibility toward coronary disease
1971
Cytokine Modulation of LDL Oxidation by Activated Human Monocytes
1997
Mutation in LDL Receptor: Alu-Alu Recombination Deletes Exons Encoding Transmembrane and Cytoplasmic Domains
1985 StandoutScienceNobel
Familial Hypercholesterolemia in a Large Kindred
1972 StandoutNobel
Prognostic Significance of Rheological and Biochemical Findings in Patients with Intermittent Claudication
1973
Aggravation of Broad-ß Disease (Type 3 Hyperlipoproteinemia) by Hypothyroidism
1972
Serial lipid and lipoprotein responses to the American Heart Association fat-controlled diet
1971
Analysis of a mutant strain of human fibroblasts with a defect in the internalization of receptor-bound low density lipoprotein
1976
The Pathogenesis of Atherosclerosis: Atherogenesis and Inflammation
1989
Type III Hyperlipoproteinemia: An Analysis of Two Contemporary Definitions
1975
Depletion of intracellular potassium arrests coated pit formation and receptor-mediated endocytosis in fibroblasts
1983 StandoutNobel
Recent progress in understanding apolipoprotein B.
1990
The Pathogenesis of Atherosclerosis
1976 Standout
Independent Pathways for Secretion of Cholesterol and Apolipoprotein E by Macrophages
1983 StandoutScienceNobel
Receptor-Mediated Control of Cholesterol Metabolism
1976 StandoutScienceNobel
CHOLESTEROL METABOLISM IN MAN
1955
Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts.
1976 StandoutNobel
Hyperlipidemia in Coronary Heart Disease I. LIPID LEVELS IN 500 SURVIVORS OF MYOCARDIAL INFARCTION
1973 StandoutNobel
Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition
1979 StandoutNobel
Identity of tumour necrosis factor and the macrophage-secreted factor cachectin
1985 StandoutNatureNobel
Hyperlipidemia and Atherosclerosis
1976 Science
Platelet deposition at high shear rates is enhanced by high plasma cholesterol levels. In vivo study in the rabbit model.
1991
PLASMA EXCHANGE FOR HYPERCHOLESTEROLAEMIA
1981
Platelet activation by plasma lipoproteins
1987
Migratory polyarthritis in familial hypercholesterolemia (type II hyperlipoproteinemia)
1968
Deficiency of low density lipoprotein receptors in liver and adrenal gland of the WHHL rabbit, an animal model of familial hypercholesterolemia.
1981 StandoutNobel
Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog.
1981 StandoutNobel
Clinical, Haemodynamic, Rheological, and Biochemical Findings in 126 Patients with Intermittent Claudication
1973
Expression of the Familial Hypercholesterolemia Gene in Heterozygotes: Mechanism for a Dominant Disorder in Man
1974 StandoutScienceNobel
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Mechanisms of action of plant sterols on inhibition of cholesterol absorption
1991
Familial Dysbetalipoproteinemia: New Aspects of Pathogenesis and Diagnosis
1982
Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.
1994
Liver Transplantation to Provide Low-Density-Lipoprotein Receptors and Lower Plasma Cholesterol in a Child with Homozygous Familial Hypercholesterolemia
1984 StandoutNobel
Works of Robert S. Lees being referenced
Practical Methods for Plasma Lipoprotein Analysis1 1Work supported in part by the U.S. Atomic Energy Commission and by grants (HE06222 and FR00102) from the U.S. Public Health Service.
1968
Measurement of the time course of peripheral vasoactivity: results in cigarette smokers
1998
New methods for arterial diameter measurement from B-mode images
1996
The QUinapril Ischemic Event Trial (QUIET) design and methods: Evaluation of chronic ACE inhibitor therapy after coronary artery intervention
1993
The Quinapril Ischemic Event Trial (QUIET): evaluation of chronic ace inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function
2001
Comparison of B-mode, M-mode and echo-tracking methods for measurement of the arterial distension waveform
1997
Immunoassay of Plasma Low-Density Lipoproteins
1970 Science
Clofibrate Reversal of Platelet Hypersensitivity in Hyperbetalipoproteinemia
1974
Failure of Complete Bile Diversion and Oral Bile Acid Therapy in the Treatment of Homozygous Familial Hypercholesterolemia
1977
Effects of an experimental viral infection on plasma lipid and lipoprotein metabolism
1972
The Treatment of Hyperlipidemia
1971
Platelet Function in Hyperlipoproteinemia
1974
Local variation in arterial wall permeability to low density lipoprotein in normal rabbit aorta.
1986
Selective accumulation of low density lipoproteins in damaged arterial wall.
1983
Plant sterols as cholesterol-lowering agents: Clinical trials in patients with hypercholesterolemia and studies of sterol balance
1977
Imaging human atherosclerosis with 99mTc-labeled low density lipoproteins.
1988
Metabolic relationships among the plasma lipoproteins
1972
The Storage Lipids in Tangier Disease
1977
Platelet function and platelet lipid composition in the dyslipoproteinemias
1980
Homozygous Familial Hypercholesterolemia
1975
Plasma-Exchange Therapy of Homozygous Familial Hypercholesterolemia
1980
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
1967 Standout
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
1967
Platelets, Intravascular Coagulation and Fibrinolysis in Hyperlipidaemias: Relationship to Thrombo‐Embolic Complications
1980
Results of colestipol therapy in type II hyperlipoproteinemia
1976
Low density lipoprotein binding to human platelets: Role of charge and of specific amino acids
1981
External imaging of human atherosclerosis.
1983
A Study of Coronary Heart Disease in Young Men
1966
Transport of 125I-albumin across normal and deendothelialized rabbit thoracic aorta in vivo.
1984
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
1967
Assay of Total Plasma Apolipoprotein B Concentration in Human Subjects
1974
Fat Transport in Abetalipoproteinemia
1969
Low density lipoprotein metabolism in Type IV and Type V hyperlipoproteinemia
1979
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
1967
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
1967